Investigational products for cancer

Oncophage® (vitespen; formerly HSPPC-96)
Patient-specific vaccine designed to treat cancer with minimal side effects

Aroplatin™
Liposomal formulation of a third-generation platinum chemotherapeutic

ATRA-IV
Liposome-encapsulated formulation of all-trans-retinoic acid

Cancer vaccines: the Antigenics approach
How Antigenics’ unique-antigen heat shock protein-based vaccine differ from others’ shared-antigen products